The long-term goal of this project is to develop a comprehensive knowledge of acute insulin signaling pathways. Much of insulin signaling proceeds by changes in the extent of phosphorylation on specific sites of proteins. The majority of these sites and the effects of their changes in phosphorylation are still unknown. We refer to all the sites in the cell that undergo changes in phosphorylation in response to acute insulin treatment as the insulin phosphoproteome. The advent of new technologies in phosphopeptide isolation and mass spectrometry now enable the comprehensive determination of the insulin phosphoproteome. Identification of a site on a protein that changes in phosphorylation in response to insulin is the first step in elucidating the functional role of the phosphorylation change in insulin action. We propose one very substantial specific aim. We will determine and analyze the insulin phosphoproteome in cultured adipocytes, myotubes, and hepatocyte-like cells. These are models for the three main target tissues of insulin action: fat, muscle and liver. Through the use of specific kinase inhibitors we will assess where each site of insulin-regulated phosphorylation is located within the currently known framework of insulin signaling. This proposed research is most directly relevant to type 2 diabetes, a disease that afflicts about 20 million Americans. A key component of type 2 diabetes is insulin resistance, the state in which cells exhibit reduced responsiveness to normal levels of insulin. The proposed research will lead to a more complete understanding of insulin signaling and action. This knowledge is a necessary basis for understanding of the changes that occur in the insulin-resistant state of type 2 diabetes.

Public Health Relevance

Insulin is the key hormone that regulates the body?s many responses to food intake. The proposed research is designed to describe more fully at the molecular level the myriad ways which insulin causes its cellular effects. This information will broaden the knowledge base for understanding type 2 diabetes, a hallmark of which is the reduced responsiveness of cells to insulin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56DK042816-20A1
Application #
8278716
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Haft, Carol R
Project Start
1990-07-01
Project End
2013-06-30
Budget Start
2011-07-15
Budget End
2013-06-30
Support Year
20
Fiscal Year
2011
Total Cost
$316,000
Indirect Cost
Name
Dartmouth College
Department
Biochemistry
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Kettenbach, Arminja N; Sano, Hiroyuki; Keller, Susanna R et al. (2015) SPECHT - single-stage phosphopeptide enrichment and stable-isotope chemical tagging: quantitative phosphoproteomics of insulin action in muscle. J Proteomics 114:48-60
Oeckinghaus, Andrea; Postler, Thomas S; Rao, Ping et al. (2014) ?B-Ras proteins regulate both NF-?B-dependent inflammation and Ral-dependent proliferation. Cell Rep 8:1793-1807
Carlson, Scott M; White, Forest M (2012) Labeling and identification of direct kinase substrates. Sci Signal 5:pl3
Lyons, Patrick D; Peck, Grantley R; Kettenbach, Arminja N et al. (2009) Insulin stimulates the phosphorylation of the exocyst protein Sec8 in adipocytes. Biosci Rep 29:229-35
Peck, Grantley R; Chavez, Jose A; Roach, William G et al. (2009) Insulin-stimulated phosphorylation of the Rab GTPase-activating protein TBC1D1 regulates GLUT4 translocation. J Biol Chem 284:30016-23